Researchers on Wednesday said an existing and approved drug might be able to stop multiple sclerosis in its tracks before people experience any symptoms of the disease.
Researchers on Wednesday said an existing and approved drug might be able to stop multiple sclerosis in its tracks before people experience any symptoms of the disease, preliminary findings that offer a very early ray of hope that patients could one day be spared the worst parts of the devastating and incurable neurological condition or even avoid it entirely.
Multiple sclerosis, often known as MS, is a degenerative and potentially disabling neurological condition thought to be caused by the immune system mistakenly attacking the protective layer that surrounds nerve cells, which disrupts signals to and from the brain and can trigger symptoms including dizziness, vision problems, paralysis and muscle weakness.
Signs of similar damage are sometimes found in the scans of people who do not have any symptoms of multiple sclerosis—termed radiologically isolated syndrome—and many will later go on to develop MS, said Dr. Christine Lebrun Frenay, of France’s University Hospital of Nice.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
DEA announces ‘Drug Take Back Day’ event in effort to curb prescription drug abuseThe yearly event allows people to safely dispose of unwanted or unused medications.
Read more »
Texas offers less support for caregivers of dementia patients than any other state, new report showsReport shows Texas ranks at No. 1 for greatest burden score, shows that caregivers for...
Read more »
Multiple people trapped after parking garage collapses in NYC | New York PostMultiple people were trapped Tuesday after a parking garage collapsed in Lower Manhattan, officials said.Shocking footage from the scene shows multiple cars ...
Read more »
US Supreme Court rebuffs Novartis bid to revive MS drug Gilenya patentThe U.S. Supreme Court on Monday declined to hear Novartis Pharmaceuticals Corp's bid to revive a key patent on its blockbuster multiple sclerosis drug Gilenya that was invalidated amid a legal dispute with China's HEC Pharm Co Ltd .
Read more »
Supreme Court Rebuffs Novartis Bid to Revive MS Drug Gilenya PatentThe Supreme Court on Monday declined to hear Novartis's bid to revive a key patent on its blockbuster multiple sclerosis drug Gilenya that was invalidated amid a legal dispute with China's HEC Pharm.
Read more »